Contrast media come under axe in Japan
This article was originally published in Clinica
Executive Summary
Imaging contrast agents will suffer the biggest price cut in Japan's general reimbursement price revision this April with an average 9.6% reduction in tariff prices. The overall price cut for medical devices is expected to be around 5-6% (see Clinica No 896, pp 1-2).